Chronic Pain News and Research RSS Feed - Chronic Pain News and Research

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Nektar Therapeutics announced today that it has received a $40 million cash payment under a license agreement with AstraZeneca. The payment was triggered by the first commercial sale of MOVENTIG (naloxegol) in Germany. [More]
Fentanyl sold as heroin causing new wave of overdose deaths

Fentanyl sold as heroin causing new wave of overdose deaths

With the heroin epidemic in the United States reaching deadlier heights, Jacksonville-based Lakeview Health drug and alcohol treatment center's Dr. Philip Hemphill is helping to explain why fentanyl is causing a new wave of overdoses. Because Fentanyl is approximately 40 to 50 times more potent than pharmaceutical grade heroin and often illegally purchased unknowingly by recreational users as heroin, the risk of death skyrockets. [More]
Researchers examine how patients handle stigma of using medical marijuana

Researchers examine how patients handle stigma of using medical marijuana

Research recently published in Journal of Psychoactive Drugs (Routledge) examines the experiences of California residents who have been prescribed medical marijuana and the stigma they experience from public opinion. The findings indicate that the stigma of using medical marijuana may contribute to the under-treatment of those who might benefit from medical marijuana. [More]
Founder of ACPA discusses how patient with chronic pain can tackle their NSAID usage

Founder of ACPA discusses how patient with chronic pain can tackle their NSAID usage

When a patient with chronic pain is experiencing symptoms, relief is only thing on their mind. NSAIDs, or nonsteroidal anti-inflammatory drugs, can often provide that relief, however it's important to balance the potential benefits with the potential risks of these drugs. [More]

Education can empower clinicians to safely prescribe opioids for chronic pain sufferers

Educating clinicians on how to safely prescribe opioids can help decrease opioid misuse among chronic pain sufferers. [More]
AMA Task Force to Reduce Opioid Abuse announces national recommendations to address opioid crisis

AMA Task Force to Reduce Opioid Abuse announces national recommendations to address opioid crisis

Opioid abuse is a serious public health problem that has reached crisis levels across the United States, with 44 people dying each day from overdose of opioids, and many more becoming addicted. Recognizing the urgency and serious impact of this issue on the health of hundreds of thousands of patients across the country, today the American Medical Association Task Force to Reduce Opioid Abuse announced the first of several national recommendations to address this growing epidemic. [More]
Nuvo Research granted U.S. patent for novel topical foam formulations that use DMSO to enhance drug delivery

Nuvo Research granted U.S. patent for novel topical foam formulations that use DMSO to enhance drug delivery

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that the United States Patent Office has granted U.S. patent no. 9,107,823 ('823 Patent) covering novel topical foam formulations that include dimethyl sulfoxide (DMSO) together with certain drug actives. [More]
Simple exercises, stretches can help eliminate postural stressors

Simple exercises, stretches can help eliminate postural stressors

Modern lifestyle factors, such as texting, reaching for your keyboard or wearing high heels, can create postural stressors that often cause muscle imbalances and injury. Having good posture is essential for good health; however, understanding what good posture is and maintaining it are hard. [More]
Researchers find potential targets to improve sleep in patients with fibromyalgia

Researchers find potential targets to improve sleep in patients with fibromyalgia

Fibromyalgia is characterized by chronic pain from no clear source. Patients with fibromyalgia frequently have sleep problems: Their deep sleep brain wave patterns are often disrupted by brain waves that correspond to wakefulness. [More]
New NIH study shows nearly 50 million U.S. adults experience chronic pain or severe pain

New NIH study shows nearly 50 million U.S. adults experience chronic pain or severe pain

Nearly 50 million American adults have significant chronic pain or severe pain, according to a new study prepared by National Institutes of Health's National Center for Complementary and Integrative Health, which appears this month in The Journal of Pain, published by the American Pain Society. [More]
BioElectronics reports Q2 financial results, publishes market surveys of ActiPatch Therapy

BioElectronics reports Q2 financial results, publishes market surveys of ActiPatch Therapy

BioElectronics Corporation, the maker of advanced drug-free consumer medical devices, today published on its second quarter financial results along with a market analysis of its long term follow up surveys of customers who are managing pain with ActiPatch Therapy. [More]
Newly developed technique delivers wireless power for optogenetics

Newly developed technique delivers wireless power for optogenetics

A miniature device that combines optogenetics - using light to control the activity of the brain - with a newly developed technique for wirelessly powering implanted devices is the first fully internal method of delivering optogenetics. [More]
BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant. [More]
Many reproductive-age women experience pelvic pain that goes untreated, study finds

Many reproductive-age women experience pelvic pain that goes untreated, study finds

A high proportion of reproductive-age women may be experiencing pelvic pain that goes untreated, according to a study by researchers from the National Institutes of Health and the University of Utah School of Medicine, Salt Lake City. [More]
Flowonix Medical's new Patient Therapy Controller approved for market release

Flowonix Medical's new Patient Therapy Controller approved for market release

Flowonix Medical, Inc., announced today that its newest product, the Patient Therapy Controller (PTC), has been approved for market release. The PTC interfaces with the company's Prometra platform of intrathecal infusion devices. A small, hand-held device with a touch-screen, the PTC allows the patient to initiate a bolus delivery of medication from the implanted pump. [More]
People with IBD experience higher anxiety risk compared to peers without IBD

People with IBD experience higher anxiety risk compared to peers without IBD

People who have inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis, have twice the odds of having a generalized anxiety disorder at some point in their lives when compared to peers without IBD, according to a new study published by University of Toronto researchers. [More]
Better pain relief options for individuals with chronic back and leg pain

Better pain relief options for individuals with chronic back and leg pain

Chronic back and leg pain sufferers in search of better pain relief options may have a new choice. According to a study published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, patients who received a novel high frequency form of spinal cord stimulation (SCS) therapy experienced significantly greater, long-term relief for both chronic back and leg pain, when compared to a traditional low frequency form of SCS therapy. [More]
Depressive symptoms, mood may predict momentary pain among patients with rheumatoid arthritis

Depressive symptoms, mood may predict momentary pain among patients with rheumatoid arthritis

Depressive symptoms and mood in the moment may predict momentary pain among rheumatoid arthritis patients, according to Penn State researchers. [More]
UC San Diego researchers receive NIH grant to test efficacy of Sanofi's pain drug in treating Chagas disease

UC San Diego researchers receive NIH grant to test efficacy of Sanofi's pain drug in treating Chagas disease

The National Center for Advancing Translational Sciences, part of the National Institutes of Health (NIH), has awarded James McKerrow, MD, PhD, director of the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, with a 2015 New Therapeutic Uses Award. [More]
Scott & White Healthcare - Round Rock now offers fully integrative medicine services to Central Texans

Scott & White Healthcare - Round Rock now offers fully integrative medicine services to Central Texans

Scott & White Healthcare - Round Rock is now offering integrative medicine services to Central Texans that include massage therapy and acupuncture at two of its regional clinics: Scott & White Clinic - Avery Ranch and Baylor Scott & White Clinic - Round Rock South. [More]
Advertisement